Search Results - "Aivazian, Karina"

Refine Results
  1. 1

    Histological regression in melanoma: impact on sentinel lymph node status and survival by Aivazian, Karina, Ahmed, Tasnia, El Sharouni, Mary-Ann, Stretch, Jonathan R., Saw, Robyn P.M., Spillane, Andrew J., Shannon, Kerwin F., Ch'ng, Sydney, Nieweg, Omgo E., Thompson, John F., Lo, Serigne N., Scolyer, Richard A.

    Published in Modern pathology (01-11-2021)
    “…Regression in melanoma is an immunological phenomenon that results in partial or complete replacement of the tumor with variably vascular fibrous tissue, often…”
    Get full text
    Journal Article
  2. 2

    Perineural invasion in oral squamous cell carcinoma: Quantitative subcategorisation of perineural invasion and prognostication by Aivazian, Karina, Ebrahimi, Ardalan, Low, Tsu-Hui (Hubert), Gao, Kan, Clifford, Anthony, Shannon, Kerwin, Clark, Jonathan R., Gupta, Ruta

    Published in Journal of surgical oncology (01-03-2015)
    “…Background Evidence regarding the prognostic value of perineural invasion (PNI) in oral squamous cell carcinoma (OSCC) and whether PNI alone warrants…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications by Aivazian, Karina

    Published in Pathology (01-03-2023)
    “…Tumour regression is an immunologically driven process that results in complete or partial disappearance of tumour cells. This can be observed in histological…”
    Get full text
    Journal Article
  6. 6

    A Rare Case of Duodenal Adenocarcinoma Presenting as a Subepithelial Lesion in a Patient Undergoing Investigation for Iron Deficiency Anaemia by Kaffes, Arthur, Wong, May, McKenzie, Catriona, Aivazian, Karina, Hu, Xinxin, Saxena, Payal

    “…Introduction. Adenocarcinomas account for approximately 40% of small bowel cancers. They are typically mucosal lesions with distinctive features on endoscopy…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma by El Sharouni, Mary-Ann, Aivazian, Karina, Witkamp, Arjen J, Sigurdsson, Vigfús, van Gils, Carla H, Scolyer, Richard A, Thompson, John F, van Diest, Paul J, Lo, Serigne N

    Published in JAMA dermatology (Chicago, Ill.) (01-02-2021)
    “…Although regression is commonly observed in cutaneous melanoma, it is uncertain whether it is associated with patient prognosis. To determine whether…”
    Get more information
    Journal Article
  11. 11

    Acute Interstitial Nephritis and Oxalate Nephropathy After Rapid Pasireotide Response in Treatment-resistant Acromegaly by Hayes, Annabelle G, Penny, Mark J, Aivazian, Karina, Greenfield, Jerry R

    Published in JCEM case reports (20-05-2024)
    “…We report a case of interstitial nephritis, likely secondary to oxalate nephropathy, due to the development of pancreatic exocrine dysfunction after…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets by Vergara, Ismael A., Aivazian, Karina, Carlino, Matteo S., Guminski, Alexander D., Maher, Nigel G., Shannon, Kerwin F., Ch’ng, Sydney, Saw, Robyn P.M., Long, Georgina V., Wilmott, James S., Scolyer, Richard A.

    Published in Modern pathology (01-04-2023)
    “…Basal cell carcinomas (BCCs) are human beings’ most common malignant tumors. Most are easily managed by surgery or topical therapies, and metastasis is rare…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modifications by Maher, Nigel G., Prosser, Natasha, Aivazian, Karina, Colebatch, Andrew J., Ferguson, Peter M., Karim, Rooshdiya Z., McKenzie, Catriona A., Rawson, Robert V., Lo, Serigne N., Scolyer, Richard A.

    Published in Pathology (01-10-2023)
    “…Diagnosis of basal cell carcinoma (BCC) higher risk subtypes influences management strategies because of their propensity to recur locally. Subtyping is prone…”
    Get full text
    Journal Article